Alto Neuroscience receives FDA Fast Track designation for ALTO-101

Calico Life Sciences' investigational treatment for ADPKD receives US FDA Fast Track Designation

Jazz Pharmaceuticals' Zepzelca (lurbinectedin) and atezolizumab (Tecentriq) combination approved by FDA in ES-SCLC

Hologic receives FDA clearance and CE mark for new gastrointestinal bacterial assays

Celltrion launches AVTOZMA IV in the United States following FDA approval

Vanda Pharmaceuticals agrees collaborative framework to resolve US FDA disputes

Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance

Pharming receives FDA priority review for leniolisib in children with APDS

Appili Therapeutics and Vitalex Biosciences secure NIAID contract for fungal vaccine development for up to USD40m

Renalytix submits CE Mark application for kidneyIntelX.dkd in Europe

Vicore Pharma's buloxibutid receives orphan drug designation in Japan

Novartis to launch US direct-to-patient platform for Cosentyx

Genmab to acquire Merus in USD8bn all-cash deal

Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI

Johnson & Johnson secures FDA approval for TREMFYA for paediatric plaque psoriasis and active psoriatic arthritis